Trial intelligence / Profile preview

Iron absorption after Roux-en-Y gastric bypass

2014-002323-10Phase 4Active

Sponsor
Rijnstate
Start
Jun 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of Ferrous gluconate in iron deficiency anemia (IDA) and obesity, sponsored by Rijnstate. Primary endpoint: Change in iron absorption pre- vs post-Roux-en-Y gastric bypass. Started Jun 2014; status: active.

02

Drugs

Ferrous gluconate
03

Conditions

iron deficiency anemia (IDA)obesity

Beyond the preview

Go deeper on 2014-002323-10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-002323-10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call